Novo Nordisk A/S (NYSE: NVO) has reportedly discontinued its long-acting insulin Levemir in the U.S., attributing the decision to manufacturing constraints, reduced patient access, and the availability of alternative options.
Oil prices are currently on a downward trend, heading for their third consecutive week of losses and reaching levels similar to those observed in mid-July: 10 cheap stocks to consider.